118 related articles for article (PubMed ID: 8970640)
21. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
Suzuki K; Tanabe K; Tokumoto T; Shimizu T; Ishikawa N; Yagisawa T; Honda K; Nihei H; Toma H
Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
[No Abstract] [Full Text] [Related]
22. Quadruple immunotherapy will promise excellent graft survival in cadaveric renal transplants using cardiac arrest donor grafts.
Hoshinaga K; Shiroki R; Higuchi T; Horiba Y; Yanaoka M; Naide Y
Transplant Proc; 1996 Jun; 28(3):1591-3. PubMed ID: 8658798
[No Abstract] [Full Text] [Related]
23. Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
Kusaba R; Otubo O; Sugimoto H; Takahashi I; Yamada Y; Yamauchi J; Akiyama N; Inou T
Proc Eur Dial Transplant Assoc; 1981; 18():420-5. PubMed ID: 7036163
[TBL] [Abstract][Full Text] [Related]
24. Studies on antinephritic effect of mizoribine (p-INN, Bredinin), a new immunosuppressive agent, and azathioprine (1) effect on the nephrotic type of anti-GBM nephritis in rats.
Okamoto K; Ito M; Suzuki Y
Jpn J Pharmacol; 1983 Jun; 33(3):541-8. PubMed ID: 6620726
[TBL] [Abstract][Full Text] [Related]
25. A prospective trial of steroid cessation after renal transplantation in pediatric patients treated with cyclosporine and mizoribine.
Motoyama O; Hasegawa A; Ohara T; Hattori M; Kawaguchi H; Takahashi K; Kamiyama Y; Nakai H; Shishido S; Ogawa O; Kawamura T; Tsuzuki K; Oshima S
Pediatr Transplant; 1997 Aug; 1(1):29-36. PubMed ID: 10084784
[TBL] [Abstract][Full Text] [Related]
26. Prolongation of canine renal allograft survival by combining tacrolimus with antimetabolic agents.
Zhu Y; Suzuki T; Subbotin VM; Ishizaki N; Jin MB; Urakami A; Shimamura T; Starzl TE; Todo S
Transplant Proc; 1997; 29(1-2):308-9. PubMed ID: 9123011
[No Abstract] [Full Text] [Related]
27. Mofetil mycophenolate in renal transplantation.
Pretagostini R; Rossi M; Berloco P; Colonnello M; Bruzzone P; Peritore D; Lonardo MT; Cortesini R
Transplant Proc; 2001; 33(1-2):1082-3. PubMed ID: 11267200
[No Abstract] [Full Text] [Related]
28. Daclizumab to prevent acute rejection in renal transplantation.
Abramowicz D
N Engl J Med; 1998 Jun; 338(23):1700-1. PubMed ID: 9616069
[No Abstract] [Full Text] [Related]
29. A prospective trial of steroid withdrawal after renal transplantation treated with cyclosporine and mizoribine in children: results obtained between 1990 and 2003.
Motoyama O; Hasegawa A; Ohara T; Satoh M; Shishido S; Honda M; Tsuzuki K; Kinukawa T; Hattori M; Ito K; Ogawa O; Yanagihara T; Saito K; Takahashi K; Ohshima S
Pediatr Transplant; 2005 Apr; 9(2):232-8. PubMed ID: 15787799
[TBL] [Abstract][Full Text] [Related]
30. Conversion from azathioprine [correction of azathioprina] to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection.
Ferraris JR; Tambutti ML; Redal MA; Bustos D; Ramirez JA; Prigoshin N
Transplantation; 2000 Jul; 70(2):297-301. PubMed ID: 10933152
[TBL] [Abstract][Full Text] [Related]
31. The case of azathioprine versus mycophenolate. Do different drugs really cause different transplant outcomes?
Craig JC; Webster AC; McDonald SP
Transplantation; 2009 Mar; 87(6):803-4. PubMed ID: 19300180
[No Abstract] [Full Text] [Related]
32. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection.
Miladipour AH; Ghods AJ; Nejadgashti H
Transplant Proc; 2002 Sep; 34(6):2089-90. PubMed ID: 12270325
[No Abstract] [Full Text] [Related]
33. Immunopharmacologic effects of immunosuppressive agents explored by a new effector monocyte generation assay.
Ishibashi M; Jiang S; Kokado Y; Takahara S; Sonoda T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1854-8. PubMed ID: 2469228
[No Abstract] [Full Text] [Related]
34. Mizoribine: mode of action and effects in clinical use.
Yokota S
Pediatr Int; 2002 Apr; 44(2):196-8. PubMed ID: 11896886
[TBL] [Abstract][Full Text] [Related]
35. Synergistic effect of cyclosporine and mizoribine on graft survival in canine organ transplantation.
Hayashi R; Suzuki S; Shimatani K; Watanabe H; Kenmochi T; Fukuoka T; Niiya S; Amemiya H
Transplant Proc; 1990 Aug; 22(4):1676-8. PubMed ID: 2389432
[No Abstract] [Full Text] [Related]
36. Effect of anti CD45 on different immunosuppressive regimes in renal transplantation.
Talbot D; Shenton BK; Bell A; White M; Glennon A; Manas D; Minford E; Rix D; Mathew A; Kumar A; Taylor RM
Transplant Proc; 1996 Dec; 28(6):3212-3. PubMed ID: 8999605
[No Abstract] [Full Text] [Related]
37. BTI-322 for induction therapy after renal transplantation: a randomized study.
Squifflet JP; Besse T; Malaise J; Mourad M; Delcorde C; Hope JA; Pirson Y
Transplant Proc; 1997; 29(1-2):317-9. PubMed ID: 9123018
[No Abstract] [Full Text] [Related]
38. Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Baker GM; Martin JE; Jang R; Schroeder TJ; Armitstead JA; Myre S; First MR
Transplant Proc; 1998 Dec; 30(8):4082-4. PubMed ID: 9865304
[No Abstract] [Full Text] [Related]
39. Monitoring azathioprine therapy in pediatric renal transplant patients with red blood cell thiopurine methyltransferase.
Dervieux T; Médard Y; Baudouin V; Maisin A; Zhang D; Loirat C; Jacqz-Aigrain E
Transplant Proc; 2000 Mar; 32(2):361-3. PubMed ID: 10715440
[No Abstract] [Full Text] [Related]
40. A new triple-drug induction therapy with low dose cyclosporine, mizoribine and prednisolone in renal transplantation.
Kokado Y; Ishibashi M; Jiang H; Takahara S; Sonoda T
Transplant Proc; 1989 Feb; 21(1 Pt 2):1575-8. PubMed ID: 2652512
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
